Shareholder plans sale of 51,076 CADE common shares on NYSE
James D. Rollins III has filed a notice of intent to sell 51,076 common shares of CADE under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
James D. Rollins III has filed a notice of intent to sell 51,076 common shares of CADE under Rule 144. The planned sale has an aggregate market value of 2,209,064.28, with an approximate sale date of 12/16/2025 on the NYSE through Fidelity Brokerage Services LLC. Shares outstanding were 183,527,575 common shares.
The shares to be sold were acquired as restricted stock vesting compensation from the issuer on three dates in 2025: 36,373 shares on 03/31/2025, 14,609 shares on 05/15/2025, and 94 shares on 12/08/2025, all paid as compensation. During the past three months, Rollins sold 23,145 common shares on 12/15/2025 for gross proceeds of 1,011,252.56.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the CADE Form 144 filing disclose?
The filing shows that James D. Rollins III intends to sell 51,076 common shares of CADE under Rule 144, detailing the planned sale terms and how the shares were acquired.
AI-generated analysis. How Rhea-AI works. Not financial advice.